Literature DB >> 12521379

Cloning of a new type II cytokine receptor activating signal transducer and activator of transcription (STAT)1, STAT2 and STAT3.

Laure Dumoutier1, Diane Lejeune, Simon Hor, Helmut Fickenscher, Jean-Christophe Renauld.   

Abstract

In the present paper, we report the identification of a new gene encoding a transmembrane protein of 520 amino acids, showing 22% amino acid identity with the extracellular domain of the interleukin (IL)-20 receptor. This gene, termed likely interleukin or cytokine receptor-2 ( LICR2 ), is located on chromosome 1, at 25 kb from the IL22R (IL-22 receptor) gene, and is constitutively expressed in most tissues. A chimaeric receptor, consisting of the extracellular domain of the IL-10 receptor alpha chain and the intracellular domain of LICR2, activated signal transducer and activator of transcription (STAT)1, STAT2, STAT3 and STAT5 upon IL-10 stimulation, in a Janus kinase 1-dependent manner. In contrast, none of the IL-10-related cytokines described so far could activate LICR2-transfected cells, suggesting that LICR2 is a signalling receptor for a new cytokine of the IL-10 family.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12521379      PMCID: PMC1223207          DOI: 10.1042/BJ20021935

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  23 in total

Review 1.  The Stat family in cytokine signaling.

Authors:  J N Ihle
Journal:  Curr Opin Cell Biol       Date:  2001-04       Impact factor: 8.382

Review 2.  Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures.

Authors:  S Goodbourn; L Didcock; R E Randall
Journal:  J Gen Virol       Date:  2000-10       Impact factor: 3.891

3.  Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease.

Authors:  Kamran Ghoreschi; Peter Thomas; Susanne Breit; Martin Dugas; Reinhard Mailhammer; Willem van Eden; Ruurd van der Zee; Tilo Biedermann; Jörg Prinz; Matthias Mack; Ulrich Mrowietz; Enno Christophers; Detlef Schlöndorff; Gerd Plewig; Christian A Sander; Martin Röcken
Journal:  Nat Med       Date:  2002-12-02       Impact factor: 53.440

Review 4.  Interleukin-10 and the interleukin-10 receptor.

Authors:  K W Moore; R de Waal Malefyt; R L Coffman; A O'Garra
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

5.  Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R.

Authors:  M H Xie; S Aggarwal; W H Ho; J Foster; Z Zhang; J Stinson; W I Wood; A D Goddard; A L Gurney
Journal:  J Biol Chem       Date:  2000-10-06       Impact factor: 5.157

Review 6.  Jak-Stat signal transduction pathway through the eyes of cytokine class II receptor complexes.

Authors:  S V Kotenko; S Pestka
Journal:  Oncogene       Date:  2000-05-15       Impact factor: 9.867

7.  Interleukin 20: discovery, receptor identification, and role in epidermal function.

Authors:  H Blumberg; D Conklin; W F Xu; A Grossmann; T Brender; S Carollo; M Eagan; D Foster; B A Haldeman; A Hammond; H Haugen; L Jelinek; J D Kelly; K Madden; M F Maurer; J Parrish-Novak; D Prunkard; S Sexson; C Sprecher; K Waggie; J West; T E Whitmore; L Yao; M K Kuechle; B A Dale; Y A Chandrasekher
Journal:  Cell       Date:  2001-01-12       Impact factor: 41.582

8.  Human interleukin-10-related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor.

Authors:  L Dumoutier; E Van Roost; D Colau; J C Renauld
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

9.  IL-4 and IL-13 regulate the induction of indoleamine 2,3-dioxygenase activity and the control of Toxoplasma gondii replication in human fibroblasts activated with IFN-gamma.

Authors:  A C Chaves; I P Cerávolo; J A Gomes; C L Zani; A J Romanha; R T Gazzinelli
Journal:  Eur J Immunol       Date:  2001-02       Impact factor: 5.532

10.  Induction of a novel cellular homolog of interleukin-10, AK155, by transformation of T lymphocytes with herpesvirus saimiri.

Authors:  A Knappe; S Hör; S Wittmann; H Fickenscher
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

View more
  46 in total

1.  Mouse STAT2 restricts early dengue virus replication.

Authors:  Joseph Ashour; Juliet Morrison; Maudry Laurent-Rolle; Alan Belicha-Villanueva; Courtney Ray Plumlee; Dabeiba Bernal-Rubio; Katherine L Williams; Eva Harris; Ana Fernandez-Sesma; Christian Schindler; Adolfo García-Sastre
Journal:  Cell Host Microbe       Date:  2010-11-18       Impact factor: 21.023

Review 2.  Investigations of interferon-lambda for the treatment of cancer.

Authors:  Andrew Stiff; William Carson
Journal:  J Innate Immun       Date:  2015-02-06       Impact factor: 7.349

Review 3.  Contribution of type III interferons to antiviral immunity: location, location, location.

Authors:  Sergei V Kotenko; Joan E Durbin
Journal:  J Biol Chem       Date:  2017-03-13       Impact factor: 5.157

Review 4.  Update on Janus kinase antagonists in inflammatory bowel disease.

Authors:  Brigid S Boland; William J Sandborn; John T Chang
Journal:  Gastroenterol Clin North Am       Date:  2014-06-24       Impact factor: 3.806

Review 5.  Type III IFNs: Beyond antiviral protection.

Authors:  Sergei V Kotenko; Amariliz Rivera; Dane Parker; Joan E Durbin
Journal:  Semin Immunol       Date:  2019-06       Impact factor: 11.130

6.  Interleukin 29 enhances expression of Toll receptor 3 and mediates antiviral signals in human keratinocytes.

Authors:  Sheng-Quan Zhang; Zheng Zhang; Xin Luo; Sen Yang; Yu Chai; Hai-Liang Huang; Xian-Yong Yin; Dao-Jun Hu; Chun-Jun Yang; Jun-Lin Liu; Xue-Jun Zhang
Journal:  Inflamm Res       Date:  2011-08-17       Impact factor: 4.575

7.  Increased expression of IL-28RA mRNA in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.

Authors:  Yu-Yan Cheng; Yu-Jun Sheng; Yan Chang; Yan Lin; Zheng-Wei Zhu; Lei-Lei Wen; Chao Yang; Lu Liu; Lu-Lu Yang; Fu-Sheng Zhou; Xiao-Dong Zheng; Xian-Yong Yin; Sheng-Quan Zhang; Yong Cui; Sen Yang; Xue-Jun Zhang
Journal:  Clin Rheumatol       Date:  2015-04-25       Impact factor: 2.980

8.  Characterization of the murine alpha interferon gene family.

Authors:  Vincent van Pesch; Hanane Lanaya; Jean-Christophe Renauld; Thomas Michiels
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

9.  Clinical significance of serum interleukin-29, interleukin-32, and tumor necrosis factor alpha levels in patients with gastric cancer.

Authors:  Kayhan Erturk; Didem Tastekin; Murat Serilmez; Elif Bilgin; Hamza Ugur Bozbey; Sezai Vatansever
Journal:  Tumour Biol       Date:  2015-07-29

10.  Interferon-lambda1 (interleukin-29) preferentially down-regulates interleukin-13 over other T helper type 2 cytokine responses in vitro.

Authors:  Shekar Srinivas; Jihong Dai; Joyce Eskdale; Grant E Gallagher; Nicholas J Megjugorac; Grant Gallagher
Journal:  Immunology       Date:  2008-06-10       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.